Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

BackgroundKetamine and its enantiomer esketamine represent promising new treatments for treatment-resistant depression (TRD). Esketamine induces acute, transient psychoactive effects. How patients perceive esketamine treatment, and which conditions facilitate optimal outcomes, remains poorly underst...

Full description

Bibliographic Details
Main Authors:	Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, Jolien Veraart, Jeanine Kamphuis, Nina Schimmel, Wim van den Brink, Eric Vermetten, Robert Schoevers
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Psychiatry
Subjects:	ketamine treatment-resistant depression (TRD) patient experience quality of care (QoC) set and setting phenomenology
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.948115/full

Similar Items

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study
by: Joost J. Breeksema, et al.
Published: (2024-02-01)

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder
by: J.K.E. Veraart, et al.
Published: (2023-05-01)

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
by: Sanne Y. Smith-Apeldoorn, et al.
Published: (2020-01-01)

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
by: Sanne Y. Smith-Apeldoorn, et al.
Published: (2022-01-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
by: Young AH, et al.
Published: (2023-02-01)

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
by: Chen X, et al.
Published: (2023-03-01)

The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
by: Marcatili Matteo, et al.
Published: (2021-09-01)

Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01)

PANSATZ: pulse-based ansatz for variational quantum algorithms
by: Dekel Meirom, et al.
Published: (2023-10-01)

Characteristics of patients expressing an interest in ketamine treatment: results of an online survey
by: Jolien K. E. Veraart, et al.
Published: (2018-09-01)

Proposal of a therapeutic algorithm for the psychopharmacological management of treatment-resistant depression
by: A. Sanz Giancola, et al.
Published: (2022-06-01)

Chebyshev Polynomials and Spectral Method for Optimal Control Problem
by: Suha Najeeb Shihab, et al.
Published: (2009-10-01)

Desarrollo de la Matriz QOC - the worker’s voice
by: Martha Roselia Contreras Valenzuela, et al.
Published: (2015-10-01)

Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy
by: Perrone V, et al.
Published: (2021-07-01)

Comparative efficacy and acceptability of seven augmentation agents for treatment-resistant depression: A multiple-treatments meta-analysis
by: Hong-Bo Qi, et al.
Published: (2014-08-01)

Symptom improvement is associated with serum cytokine level change during RTMS tretament in patients with treatment resistant depression
by: J. Lazary, et al.
Published: (2021-04-01)

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
by: Matteo Marcatili, et al.
Published: (2022-09-01)

Trend and geo-availability of somatic therapies for treatment resistant depression in the US
by: Tajudeen Basiru, et al.
Published: (2024-03-01)

Efficacy and safety of intermittent theta burst stimulation (iTBS) in treatment resistant depression
by: E. Kavakbasi, et al.
Published: (2022-06-01)

Treatment-Resistant Depression in Poland—Epidemiology and Treatment
by: Piotr Gałecki, et al.
Published: (2022-01-01)

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
by: Aye-Mu Myint, et al.
Published: (2022-06-01)

Autocatalytic Sets and the Origin of Life
by: Wim Hordijk, et al.
Published: (2010-06-01)

Ars Amatoria - trd prevajalski oreh?
by: Barbara Šega Čeh
Published: (2000-12-01)

Multilayer-Forming Behavior of Cr Nitrides and Carbides for Thermoreactive Deposition
by: Kyeongmo Park, et al.
Published: (2018-05-01)

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
by: Laurent Elkrief, et al.
Published: (2022-09-01)

Biological correlates of treatment resistant depression: a review of peripheral biomarkers
by: Emiliana Mancuso, et al.
Published: (2023-10-01)

Dynamic Reconfiguration of a RGBD Sensor Based on QoS and QoC Requirements in Distributed Systems
by: Eduardo Munera, et al.
Published: (2015-07-01)

Understanding the Link Between Burnout and Sub-Optimal Care: Why Should Healthcare Education Be Interested in Employee Silence?
by: Anthony Montgomery, et al.
Published: (2022-03-01)

Smoking cessation in inpatient psychiatry treatment facilities: A review
by: Robert Kagabo, et al.
Published: (2020-06-01)

Bilateral sequential theta burst stimulation in depressed veterans with service related posttraumatic stress disorder: a feasibility study
by: Thelepa Vaithianathan, et al.
Published: (2022-02-01)

Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus
by: Xiaohan Yan, et al.
Published: (2020-07-01)

Substance use disorders, trauma, and PTSD
by: Wim Van den Brink
Published: (2015-04-01)

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
by: Brittany Chubbs, et al.
Published: (2022-11-01)

Effects of Drop Sets on Skeletal Muscle Hypertrophy: A Systematic Review and Meta-analysis
by: Lena Kristiansen Sødal, et al.
Published: (2023-07-01)

Sheep TRD@ locus consists of a large number of TRDV elements
by: S. Ciccarese, et al.
Published: (2011-03-01)

Cervical muscle stiffness and parasympathetic nervous system improvements for treatment-resistant depression
by: Takayoshi Matsui, et al.
Published: (2022-10-01)

Cache Performance Optimization of QoC Framework
by: Asif Laghari, et al.
Published: (2019-03-01)

Integrating entropy-weighted water quality index and multiple pollution indices towards a better understanding of drinking water quality in Ojoto area, SE Nigeria
by: Johnbosco C. Egbueri, et al.
Published: (2020-11-01)

Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
by: Massimiliano Buoli, et al.
Published: (2022-02-01)